English
简体中文
Total: £ 56.28
Published Date: 2026-01-23 | Pages: 135 | Tables: 130 | Medical Care
The global siRNA Conjugates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on siRNA Conjugates competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
RNA interference (RNAi) has revolutionized gene therapy, with small interfering RNA (siRNA) being a key player in silencing disease-causing genes. However, challenges in efficient delivery and off-target effects have limited its full therapeutic application. siRNA conjugates represent a sophisticated strategy to enhance the stability, delivery, and specificity of siRNA-based therapeutics.siRNA conjugates involve the chemical attachment of siRNA molecules to various functional groups, carriers, or ligands to improve their cellular uptake, stability, and therapeutic potential. These conjugates offer several advantages, including targeted delivery to specific tissues or cells, enhanced resistance to enzymatic degradation, and reduced off-target effects. The core strategy behind siRNA conjugation is to overcome the barriers of free siRNA, such as poor cellular uptake, rapid clearance, and undesired immune responses, thus ensuring more efficient gene silencing.
The North American market for siRNA Conjugates is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for siRNA Conjugates is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of siRNA Conjugates include WuXi XDC, Creative Biogene, Bachem, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, Hitgen, Alnylam Pharmaceuticals,, Amerigo Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global siRNA Conjugates market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding siRNA Conjugates. The siRNA Conjugates market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global siRNA Conjugates market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist siRNA Conjugates manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
WuXi XDC
Creative Biogene
Bachem
LGC Biosearch Technologies
Sinopep
Organix
CD Formulation
Hitgen
Alnylam Pharmaceuticals,
Amerigo Scientific
BOCSCI Inc.
Creative Biolabs
Bio-Synthesis Inc
Creative Peptide
GenSript
Suzhou Biosyntech
Segment by Type
Antibody-siRNA Conjugates
GalNAc-siRNA Conjugates
Peptide-siRNA Conjugates
Other
by Application
Gene Therapy
Drug Delivery
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for siRNA Conjugates manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines siRNA Conjugates sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 siRNA Conjugates Market Overview
1.1 Product Definition
1.2 siRNA Conjugates by Type
1.2.1 Global siRNA Conjugates Market Value by Type: 2025 vs 2032
1.2.2 Antibody-siRNA Conjugates
1.2.3 GalNAc-siRNA Conjugates
1.2.4 Peptide-siRNA Conjugates
1.2.5 Other
1.3 siRNA Conjugates by Application
1.3.1 Global siRNA Conjugates Market Value by Application: 2025 vs 2032
1.3.2 Gene Therapy
1.3.3 Drug Delivery
1.3.4 Other
1.4 Global siRNA Conjugates Market Size Estimates and Forecasts
1.4.1 Global siRNA Conjugates Revenue 2021–2032
1.4.2 Global siRNA Conjugates Sales 2021–2032
1.4.3 Global siRNA Conjugates Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 siRNA Conjugates Market Competition by Manufacturers
2.1 Global siRNA Conjugates Sales Market Share by Manufacturers (2021–2026)
2.2 Global siRNA Conjugates Revenue Market Share by Manufacturers (2021–2026)
2.3 Global siRNA Conjugates Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of siRNA Conjugates, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of siRNA Conjugates, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of siRNA Conjugates, Product Types and Applications
2.7 Global Key Manufacturers of siRNA Conjugates, Date of Entry into the Industry
2.8 Global siRNA Conjugates Market Competitive Situation and Trends
2.8.1 Global siRNA Conjugates Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global siRNA Conjugates Players Market Share by Revenue
2.8.3 Global siRNA Conjugates Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global siRNA Conjugates Market Scenario by Region
3.1 Global siRNA Conjugates Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global siRNA Conjugates Sales by Region: 2021–2032
3.2.1 Global siRNA Conjugates Sales by Region: 2021–2026
3.2.2 Global siRNA Conjugates Sales by Region: 2027–2032
3.3 Global siRNA Conjugates Revenue by Region: 2021–2032
3.3.1 Global siRNA Conjugates Revenue by Region: 2021–2026
3.3.2 Global siRNA Conjugates Revenue by Region: 2027–2032
3.4 North America siRNA Conjugates Market Facts & Figures by Country
3.4.1 North America siRNA Conjugates Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America siRNA Conjugates Sales by Country (2021–2032)
3.4.3 North America siRNA Conjugates Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe siRNA Conjugates Market Facts & Figures by Country
3.5.1 Europe siRNA Conjugates Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe siRNA Conjugates Sales by Country (2021–2032)
3.5.3 Europe siRNA Conjugates Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific siRNA Conjugates Market Facts & Figures by Region
3.6.1 Asia Pacific siRNA Conjugates Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific siRNA Conjugates Sales by Region (2021–2032)
3.6.3 Asia Pacific siRNA Conjugates Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America siRNA Conjugates Market Facts & Figures by Country
3.7.1 Latin America siRNA Conjugates Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America siRNA Conjugates Sales by Country (2021–2032)
3.7.3 Latin America siRNA Conjugates Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa siRNA Conjugates Market Facts & Figures by Country
3.8.1 Middle East and Africa siRNA Conjugates Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa siRNA Conjugates Sales by Country (2021–2032)
3.8.3 Middle East and Africa siRNA Conjugates Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global siRNA Conjugates Sales by Type (2021–2032)
4.1.1 Global siRNA Conjugates Sales by Type (2021–2026)
4.1.2 Global siRNA Conjugates Sales by Type (2027–2032)
4.1.3 Global siRNA Conjugates Sales Market Share by Type (2021–2032)
4.2 Global siRNA Conjugates Revenue by Type (2021–2032)
4.2.1 Global siRNA Conjugates Revenue by Type (2021–2026)
4.2.2 Global siRNA Conjugates Revenue by Type (2027–2032)
4.2.3 Global siRNA Conjugates Revenue Market Share by Type (2021–2032)
4.3 Global siRNA Conjugates Price by Type (2021–2032)
5 Segment by Application
5.1 Global siRNA Conjugates Sales by Application (2021–2032)
5.1.1 Global siRNA Conjugates Sales by Application (2021–2026)
5.1.2 Global siRNA Conjugates Sales by Application (2027–2032)
5.1.3 Global siRNA Conjugates Sales Market Share by Application (2021–2032)
5.2 Global siRNA Conjugates Revenue by Application (2021–2032)
5.2.1 Global siRNA Conjugates Revenue by Application (2021–2026)
5.2.2 Global siRNA Conjugates Revenue by Application (2027–2032)
5.2.3 Global siRNA Conjugates Revenue Market Share by Application (2021–2032)
5.3 Global siRNA Conjugates Price by Application (2021–2032)
6 Key Companies Profiled
6.1 WuXi XDC
6.1.1 WuXi XDC Company Information
6.1.2 WuXi XDC Description and Business Overview
6.1.3 WuXi XDC siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 WuXi XDC siRNA Conjugates Product Portfolio
6.1.5 WuXi XDC Recent Developments/Updates
6.2 Creative Biogene
6.2.1 Creative Biogene Company Information
6.2.2 Creative Biogene Description and Business Overview
6.2.3 Creative Biogene siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Creative Biogene siRNA Conjugates Product Portfolio
6.2.5 Creative Biogene Recent Developments/Updates
6.3 Bachem
6.3.1 Bachem Company Information
6.3.2 Bachem Description and Business Overview
6.3.3 Bachem siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bachem siRNA Conjugates Product Portfolio
6.3.5 Bachem Recent Developments/Updates
6.4 LGC Biosearch Technologies
6.4.1 LGC Biosearch Technologies Company Information
6.4.2 LGC Biosearch Technologies Description and Business Overview
6.4.3 LGC Biosearch Technologies siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 LGC Biosearch Technologies siRNA Conjugates Product Portfolio
6.4.5 LGC Biosearch Technologies Recent Developments/Updates
6.5 Sinopep
6.5.1 Sinopep Company Information
6.5.2 Sinopep Description and Business Overview
6.5.3 Sinopep siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sinopep siRNA Conjugates Product Portfolio
6.5.5 Sinopep Recent Developments/Updates
6.6 Organix
6.6.1 Organix Company Information
6.6.2 Organix Description and Business Overview
6.6.3 Organix siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Organix siRNA Conjugates Product Portfolio
6.6.5 Organix Recent Developments/Updates
6.7 CD Formulation
6.7.1 CD Formulation Company Information
6.7.2 CD Formulation Description and Business Overview
6.7.3 CD Formulation siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 CD Formulation siRNA Conjugates Product Portfolio
6.7.5 CD Formulation Recent Developments/Updates
6.8 Hitgen
6.8.1 Hitgen Company Information
6.8.2 Hitgen Description and Business Overview
6.8.3 Hitgen siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hitgen siRNA Conjugates Product Portfolio
6.8.5 Hitgen Recent Developments/Updates
6.9 Alnylam Pharmaceuticals,
6.9.1 Alnylam Pharmaceuticals, Company Information
6.9.2 Alnylam Pharmaceuticals, Description and Business Overview
6.9.3 Alnylam Pharmaceuticals, siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Alnylam Pharmaceuticals, siRNA Conjugates Product Portfolio
6.9.5 Alnylam Pharmaceuticals, Recent Developments/Updates
6.10 Amerigo Scientific
6.10.1 Amerigo Scientific Company Information
6.10.2 Amerigo Scientific Description and Business Overview
6.10.3 Amerigo Scientific siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Amerigo Scientific siRNA Conjugates Product Portfolio
6.10.5 Amerigo Scientific Recent Developments/Updates
6.11 BOCSCI Inc.
6.11.1 BOCSCI Inc. Company Information
6.11.2 BOCSCI Inc. Description and Business Overview
6.11.3 BOCSCI Inc. siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BOCSCI Inc. siRNA Conjugates Product Portfolio
6.11.5 BOCSCI Inc. Recent Developments/Updates
6.12 Creative Biolabs
6.12.1 Creative Biolabs Company Information
6.12.2 Creative Biolabs Description and Business Overview
6.12.3 Creative Biolabs siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Creative Biolabs siRNA Conjugates Product Portfolio
6.12.5 Creative Biolabs Recent Developments/Updates
6.13 Bio-Synthesis Inc
6.13.1 Bio-Synthesis Inc Company Information
6.13.2 Bio-Synthesis Inc Description and Business Overview
6.13.3 Bio-Synthesis Inc siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Bio-Synthesis Inc siRNA Conjugates Product Portfolio
6.13.5 Bio-Synthesis Inc Recent Developments/Updates
6.14 Creative Peptide
6.14.1 Creative Peptide Company Information
6.14.2 Creative Peptide Description and Business Overview
6.14.3 Creative Peptide siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Creative Peptide siRNA Conjugates Product Portfolio
6.14.5 Creative Peptide Recent Developments/Updates
6.15 GenSript
6.15.1 GenSript Company Information
6.15.2 GenSript Description and Business Overview
6.15.3 GenSript siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 GenSript siRNA Conjugates Product Portfolio
6.15.5 GenSript Recent Developments/Updates
6.16 Suzhou Biosyntech
6.16.1 Suzhou Biosyntech Company Information
6.16.2 Suzhou Biosyntech Description and Business Overview
6.16.3 Suzhou Biosyntech siRNA Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Suzhou Biosyntech siRNA Conjugates Product Portfolio
6.16.5 Suzhou Biosyntech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 siRNA Conjugates Industry Chain Analysis
7.2 siRNA Conjugates Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 siRNA Conjugates Production Mode & Process Analysis
7.4 siRNA Conjugates Sales and Marketing
7.4.1 siRNA Conjugates Sales Channels
7.4.2 siRNA Conjugates Distributors
7.5 siRNA Conjugates Customer Analysis
8 siRNA Conjugates Market Dynamics
8.1 siRNA Conjugates Industry Trends
8.2 siRNA Conjugates Market Drivers
8.3 siRNA Conjugates Market Challenges
8.4 siRNA Conjugates Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global siRNA Conjugates Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global siRNA Conjugates Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global siRNA Conjugates Market Competitive Situation by Manufacturers in 2025
Table 4. Global siRNA Conjugates Sales (Kg) of Key Manufacturers (2021–2026)
Table 5. Global siRNA Conjugates Sales Market Share by Manufacturers (2021–2026)
Table 6. Global siRNA Conjugates Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global siRNA Conjugates Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market siRNA Conjugates Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of siRNA Conjugates, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of siRNA Conjugates, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of siRNA Conjugates, Product Types and Applications
Table 12. Global Key Manufacturers of siRNA Conjugates, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global siRNA Conjugates Companies by Tier (Tier 1, Tier 2, Tier 3), based on siRNA Conjugates Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global siRNA Conjugates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global siRNA Conjugates Sales by Region (Kg), 2021–2026
Table 18. Global siRNA Conjugates Sales Market Share by Region (2021–2026)
Table 19. Global siRNA Conjugates Sales by Region (Kg), 2027–2032
Table 20. Global siRNA Conjugates Sales Market Share by Region (2027–2032)
Table 21. Global siRNA Conjugates Revenue by Region (US$ Million), 2021–2026
Table 22. Global siRNA Conjugates Revenue Market Share by Region (2021–2026)
Table 23. Global siRNA Conjugates Revenue by Region (US$ Million), 2027–2032
Table 24. Global siRNA Conjugates Revenue Market Share by Region (2027–2032)
Table 25. North America siRNA Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America siRNA Conjugates Sales by Country (Kg), 2021–2026
Table 27. North America siRNA Conjugates Sales by Country (Kg), 2027–2032
Table 28. North America siRNA Conjugates Revenue by Country (US$ Million), 2021–2026
Table 29. North America siRNA Conjugates Revenue by Country (US$ Million), 2027–2032
Table 30. Europe siRNA Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe siRNA Conjugates Sales by Country (Kg), 2021–2026
Table 32. Europe siRNA Conjugates Sales by Country (Kg), 2027–2032
Table 33. Europe siRNA Conjugates Revenue by Country (US$ Million), 2021–2026
Table 34. Europe siRNA Conjugates Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific siRNA Conjugates Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific siRNA Conjugates Sales by Region (Kg), 2021–2026
Table 37. Asia Pacific siRNA Conjugates Sales by Region (Kg), 2027–2032
Table 38. Asia Pacific siRNA Conjugates Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific siRNA Conjugates Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America siRNA Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America siRNA Conjugates Sales by Country (Kg), 2021–2026
Table 42. Latin America siRNA Conjugates Sales by Country (Kg), 2027–2032
Table 43. Latin America siRNA Conjugates Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America siRNA Conjugates Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa siRNA Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa siRNA Conjugates Sales by Country (Kg), 2021–2026
Table 47. Middle East and Africa siRNA Conjugates Sales by Country (Kg), 2027–2032
Table 48. Middle East and Africa siRNA Conjugates Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa siRNA Conjugates Revenue by Country (US$ Million), 2027–2032
Table 50. Global siRNA Conjugates Sales (Kg) by Type (2021–2026)
Table 51. Global siRNA Conjugates Sales (Kg) by Type (2027–2032)
Table 52. Global siRNA Conjugates Sales Market Share by Type (2021–2026)
Table 53. Global siRNA Conjugates Sales Market Share by Type (2027–2032)
Table 54. Global siRNA Conjugates Revenue (US$ Million) by Type (2021–2026)
Table 55. Global siRNA Conjugates Revenue (US$ Million) by Type (2027–2032)
Table 56. Global siRNA Conjugates Revenue Market Share by Type (2021–2026)
Table 57. Global siRNA Conjugates Revenue Market Share by Type (2027–2032)
Table 58. Global siRNA Conjugates Price (US$/g) by Type (2021–2026)
Table 59. Global siRNA Conjugates Price (US$/g) by Type (2027–2032)
Table 60. Global siRNA Conjugates Sales (Kg) by Application (2021–2026)
Table 61. Global siRNA Conjugates Sales (Kg) by Application (2027–2032)
Table 62. Global siRNA Conjugates Sales Market Share by Application (2021–2026)
Table 63. Global siRNA Conjugates Sales Market Share by Application (2027–2032)
Table 64. Global siRNA Conjugates Revenue (US$ Million) by Application (2021–2026)
Table 65. Global siRNA Conjugates Revenue (US$ Million) by Application (2027–2032)
Table 66. Global siRNA Conjugates Revenue Market Share by Application (2021–2026)
Table 67. Global siRNA Conjugates Revenue Market Share by Application (2027–2032)
Table 68. Global siRNA Conjugates Price (US$/g) by Application (2021–2026)
Table 69. Global siRNA Conjugates Price (US$/g) by Application (2027–2032)
Table 70. WuXi XDC Company Information
Table 71. WuXi XDC Description and Business Overview
Table 72. WuXi XDC siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. WuXi XDC siRNA Conjugates Product
Table 74. WuXi XDC Recent Developments/Updates
Table 75. Creative Biogene Company Information
Table 76. Creative Biogene Description and Business Overview
Table 77. Creative Biogene siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. Creative Biogene siRNA Conjugates Product
Table 79. Creative Biogene Recent Developments/Updates
Table 80. Bachem Company Information
Table 81. Bachem Description and Business Overview
Table 82. Bachem siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Bachem siRNA Conjugates Product
Table 84. Bachem Recent Developments/Updates
Table 85. LGC Biosearch Technologies Company Information
Table 86. LGC Biosearch Technologies Description and Business Overview
Table 87. LGC Biosearch Technologies siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. LGC Biosearch Technologies siRNA Conjugates Product
Table 89. LGC Biosearch Technologies Recent Developments/Updates
Table 90. Sinopep Company Information
Table 91. Sinopep Description and Business Overview
Table 92. Sinopep siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 93. Sinopep siRNA Conjugates Product
Table 94. Sinopep Recent Developments/Updates
Table 95. Organix Company Information
Table 96. Organix Description and Business Overview
Table 97. Organix siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 98. Organix siRNA Conjugates Product
Table 99. Organix Recent Developments/Updates
Table 100. CD Formulation Company Information
Table 101. CD Formulation Description and Business Overview
Table 102. CD Formulation siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 103. CD Formulation siRNA Conjugates Product
Table 104. CD Formulation Recent Developments/Updates
Table 105. Hitgen Company Information
Table 106. Hitgen Description and Business Overview
Table 107. Hitgen siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 108. Hitgen siRNA Conjugates Product
Table 109. Hitgen Recent Developments/Updates
Table 110. Alnylam Pharmaceuticals, Company Information
Table 111. Alnylam Pharmaceuticals, Description and Business Overview
Table 112. Alnylam Pharmaceuticals, siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 113. Alnylam Pharmaceuticals, siRNA Conjugates Product
Table 114. Alnylam Pharmaceuticals, Recent Developments/Updates
Table 115. Amerigo Scientific Company Information
Table 116. Amerigo Scientific Description and Business Overview
Table 117. Amerigo Scientific siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 118. Amerigo Scientific siRNA Conjugates Product
Table 119. Amerigo Scientific Recent Developments/Updates
Table 120. BOCSCI Inc. Company Information
Table 121. BOCSCI Inc. Description and Business Overview
Table 122. BOCSCI Inc. siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 123. BOCSCI Inc. siRNA Conjugates Product
Table 124. BOCSCI Inc. Recent Developments/Updates
Table 125. Creative Biolabs Company Information
Table 126. Creative Biolabs Description and Business Overview
Table 127. Creative Biolabs siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 128. Creative Biolabs siRNA Conjugates Product
Table 129. Creative Biolabs Recent Developments/Updates
Table 130. Bio-Synthesis Inc Company Information
Table 131. Bio-Synthesis Inc Description and Business Overview
Table 132. Bio-Synthesis Inc siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 133. Bio-Synthesis Inc siRNA Conjugates Product
Table 134. Bio-Synthesis Inc Recent Developments/Updates
Table 135. Creative Peptide Company Information
Table 136. Creative Peptide Description and Business Overview
Table 137. Creative Peptide siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 138. Creative Peptide siRNA Conjugates Product
Table 139. Creative Peptide Recent Developments/Updates
Table 140. GenSript Company Information
Table 141. GenSript Description and Business Overview
Table 142. GenSript siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 143. GenSript siRNA Conjugates Product
Table 144. GenSript Recent Developments/Updates
Table 145. Suzhou Biosyntech Company Information
Table 146. Suzhou Biosyntech Description and Business Overview
Table 147. Suzhou Biosyntech siRNA Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 148. Suzhou Biosyntech siRNA Conjugates Product
Table 149. Suzhou Biosyntech Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. siRNA Conjugates Distributors List
Table 153. siRNA Conjugates Customers List
Table 154. siRNA Conjugates Market Trends
Table 155. siRNA Conjugates Market Drivers
Table 156. siRNA Conjugates Market Challenges
Table 157. siRNA Conjugates Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of siRNA Conjugates
Figure 2. Global siRNA Conjugates Market Value by Type (US$ Million), 2021–2032
Figure 3. Global siRNA Conjugates Market Share by Type: 2025 & 2032
Figure 4. Antibody-siRNA Conjugates Product Picture
Figure 5. GalNAc-siRNA Conjugates Product Picture
Figure 6. Peptide-siRNA Conjugates Product Picture
Figure 7. Other Product Picture
Figure 8. Global siRNA Conjugates Market Value by Application (US$ Million), 2021–2032
Figure 9. Global siRNA Conjugates Market Share by Application: 2025 & 2032
Figure 10. Gene Therapy
Figure 11. Drug Delivery
Figure 12. Other
Figure 13. Global siRNA Conjugates Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global siRNA Conjugates Market Size (US$ Million), 2021–2032
Figure 15. Global siRNA Conjugates Sales (Kg), 2021–2032
Figure 16. Global siRNA Conjugates Average Price (US$/g), 2021–2032
Figure 17. siRNA Conjugates Report Years Considered
Figure 18. siRNA Conjugates Sales Share by Manufacturers in 2025
Figure 19. Global siRNA Conjugates Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global siRNA Conjugates Players: Market Share by Revenue in siRNA Conjugates in 2025
Figure 21. siRNA Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global siRNA Conjugates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America siRNA Conjugates Sales Market Share by Country (2021–2032)
Figure 24. North America siRNA Conjugates Revenue Market Share by Country (2021–2032)
Figure 25. United States siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe siRNA Conjugates Sales Market Share by Country (2021–2032)
Figure 28. Europe siRNA Conjugates Revenue Market Share by Country (2021–2032)
Figure 29. Germany siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific siRNA Conjugates Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific siRNA Conjugates Revenue Market Share by Region (2021–2032)
Figure 36. China siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America siRNA Conjugates Sales Market Share by Country (2021–2032)
Figure 44. Latin America siRNA Conjugates Revenue Market Share by Country (2021–2032)
Figure 45. Mexico siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa siRNA Conjugates Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa siRNA Conjugates Revenue Market Share by Country (2021–2032)
Figure 51. Turkey siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE siRNA Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of siRNA Conjugates by Type (2021–2032)
Figure 55. Global Revenue Market Share of siRNA Conjugates by Type (2021–2032)
Figure 56. Global siRNA Conjugates Price (US$/g) by Type (2021–2032)
Figure 57. Global Sales Market Share of siRNA Conjugates by Application (2021–2032)
Figure 58. Global Revenue Market Share of siRNA Conjugates by Application (2021–2032)
Figure 59. Global siRNA Conjugates Price (US$/g) by Application (2021–2032)
Figure 60. siRNA Conjugates Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
